Related Experiment Videos
Immunization against HCG
1Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.
Human Reproduction (Oxford, England)
|February 1, 1994
Summary
Birth control vaccines targeting human chorionic gonadotrophin (HCG) are in clinical trials. These safe and effective vaccines offer a new family planning method for men and women.
Area of Science:
- Immunology
- Reproductive Health
- Vaccinology
Background:
- The concept of immunological contraception has existed since early immunology.
- Significant research over decades aims to develop safe and effective birth control vaccines for all reproductive ages.
- Current advanced research focuses on vaccines targeting human chorionic gonadotrophin (HCG).
Purpose of the Study:
- To develop and clinically test birth control vaccines for men and women.
- To create a novel family planning method utilizing the immune system.
- To advance vaccine development against HCG for effective contraception.
Main Methods:
- Development of prototype vaccines targeting different parts of the HCG molecule.
- Clinical testing of HCG-based vaccines.
- Research into improved vaccine formulations for extended protection.
Main Results:
- Prototype HCG vaccines have reached the clinical testing phase.
- No adverse side effects have been reported in clinical trials to date.
- Larger scale studies are planned to further evaluate safety and efficacy.
Conclusions:
- HCG vaccines represent a promising new avenue for family planning.
- The development of these vaccines is nearing the introduction phase.
- Immunological contraception offers a potentially revolutionary family planning method.